DTIL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -0.93% compare to its pairs and should correct downwards.

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States...

Stats
Today's Volume	67 114
Average Volume	57 120
Market Cap	68.49M
EPS	$1.700 ( Q1 \| 2024-05-13 )
Next earnings date	( $-0.770 ) 2024-08-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.760 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0600 (0.61%)

AADI -2.74%

ABCL -6.08%

ABCM 0.04%

ABEO -0.94%

ABIO -0.78%

ABOS -1.45%

ABSI -2.27%

ABUS 0.97%

ABVX 2.57%

ACAD -1.29%

ACER -17.95%

ACET -4.96%

ACGN 1.29%

ACHL -1.60%

ACHV 1.70%

ACIU -0.25%

ACLX -2.88%

ACRV 1.03%

ACST -2.34%

ACXP -4.89%

ADAG -0.33%

ADAP 7.70%

ADGI 0.87%

ADIL -5.22%

ADMA 3.31%

ADPT -0.55%

ADTX 14.49%

ADVM 1.60%

ADXN -12.26%

AEON -0.95%

AEZS 3.07%

AFMD -0.73%

AGEN -0.36%

AGIO 0.60%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.51%

AKRO -1.28%

AKTX 15.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.81%

ALEC -2.64%

ALGS 5.43%

ALKS 1.20%

ALLK -12.02%

ALLO 0.00%

ALLR 6.44%

ALNA 3.16%

ALNY 0.13%

ALPN 0.02%

ALPX 0.00%

ALRN 1.08%

ALT 8.27%

ALVR 0.93%

ALXN 0.00%

ALXO -0.66%

ALZN 0.91%

AMRN -0.29%

AMTI -3.13%

ANAB -1.80%

ANEB -1.83%

ANGN 0.00%

ANIX 0.45%

ANL -6.05%

ANNX 3.06%

ANPC -3.15%

APGE -1.96%

APGN 8.48%

APGNW 30.65%

APLM 0.96%

APLS -5.40%

APLT -1.28%

APM -7.51%

APOP 0.38%

APRE -0.98%

APTO -1.51%

APTX 3.17%

APVO 9.15%

ARAV -13.39%

ARCT -2.83%

ARDS 19.76%

ARDX 2.16%

ARGX 0.97%

ARNA 0.00%

ARPO -0.90%

ARQT 2.80%

ARTL -3.57%

ARTLW 0.00%

ARVN -2.40%

ARWR 0.23%

ASLN 0.00%

ASMB -3.50%

ASND -1.76%

ATAI 1.50%

ATHA -5.28%

ATHE 0.00%

ATHX -33.50%

ATNF -7.98%

ATOS 0.84%

ATRA -1.65%

ATXI -2.86%

ATXS 1.65%

AUPH -3.85%

AURA -2.51%

AUTL -0.29%

AVBP -2.16%

AVEO 0.00%

AVIR 1.81%

AVRO -1.41%

AVTE 2.41%

AVTX 1.12%

AVXL -2.61%

AXLA 0.00%

AXSM 0.66%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -0.51%

BCAB -1.46%

BCDA 0.67%

BCDAW 0.00%

BCEL 0.00%

BCLI 5.47%

BCRX 7.93%

BCTX -4.39%

BCTXW 17.17%

BCYC 0.25%

BDRX -0.23%

BDTX 0.86%

BEAM -1.62%

BFRA -2.91%

BGNE 1.56%

BIOR -4.56%

BIVI 4.00%

BLCM -6.68%

BLI -5.88%

BLPH -1.93%

BLRX -1.06%

BLTE 0.31%

BLU 0.03%

BLUE -0.90%

BMEA -1.78%

BMRN -0.24%

BNOX -10.04%

BNTC 3.92%

BNTX -1.90%

BOLD 8.27%

BOLT -2.41%

BPMC 1.30%

BPTH -3.00%

BPTS -13.47%

BRNS 2.14%

BRTX -2.46%

BTAI -8.59%

BTTX -15.97%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.92%

CABA 4.41%

CADL 1.61%

CALA 0.00%

CALC 7.32%

CALT -0.62%

CAPR 1.47%

CARA 1.94%

CARM 9.87%

CASI -1.82%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.89%

CCCC 4.98%

CCXI 0.00%

CDAK 0.00%

CDIO -1.82%

CDIOW 6.00%

CDMO -0.28%

CDMOP 0.04%

CDT -6.12%

CDTTW 72.08%

CDTX 0.84%

CDXC -1.47%

CDXS -3.55%

CELC 1.59%

CELU 1.92%

CELUW 1.32%

CERC -1.68%

CERE 1.13%

CERO -8.16%

CEROW 43.57%

CFRX -27.95%

CGEM -4.07%

CGEN 4.17%

CGON 0.48%

CGTX 0.60%

CHMA -6.00%

CHRS -6.94%

CINC 0.00%

CING 7.50%

CINGW 4.85%

CKPT -4.65%

CLBS -16.75%

CLDX 5.35%

CLGN 1.00%

CLLS 3.48%

CLNN 0.22%

CLNNW 44.05%

CLRB 2.00%

CLSD -4.62%

CLSN -0.68%

CLVS 0.00%

CMMB 5.00%

CMND -1.19%

CMPI 0.00%

CMPX -5.45%

CMRA 0.00%

CMRAW 33.33%

CMRX -0.80%

CNCE 0.00%

CNSP -10.13%

CNST 0.00%

CNTA -2.55%

CNTB -5.26%

CNTX -9.73%

COCP 3.00%

COEPW 0.00%

COGT 6.05%

CORT 0.55%

COYA 0.66%

CPRX 1.81%

CRBP 9.17%

CRBU -3.05%

CRDF -7.66%

CRGX -2.56%

CRIS -7.54%

CRNX 2.86%

CRSP -0.11%

CRTX 2.63%

CRVO -5.84%

CRVS 1.65%

CSBR -4.26%

CTCX 23.31%

CTIC 0.06%

CTMX 9.02%

CTNM 19.25%

CTXR -6.92%

CUE -17.74%

CVAC -2.06%

CVKD -1.15%

CWBR 0.00%

CYAD -12.96%

CYCC 0.00%

CYCCP -11.68%

CYCN 0.88%

CYT -2.27%

CYTK 0.96%

CYTO 9.91%

DARE -6.03%

DAWN -1.45%

DBTX -0.81%

DBVT 2.20%

DFFN 10.28%

DICE 0.06%

DMAC 0.00%

DNLI -5.21%

DNTH 11.55%

DOMH 4.81%

DRMA -5.37%

DRMAW 7.69%

DRNA 0.00%

DRTS 0.79%

DRTSW 19.05%

DRUG -2.77%

DSGN -2.99%

DTIL 1.64%

DYAI 3.38%

EARS -1.77%

EDIT -1.28%

EDSA 2.09%

EFTR -8.00%

EFTRW -41.67%

EIGR -9.21%

ELAB 0.07%

ELDN -4.92%

ELEV 5.93%

ELOX 1.45%

ELTX -8.03%

ELVN -2.87%

ELYM -0.84%

ENGN -4.03%

ENGNW -2.88%

ENLV -2.82%

ENOB 1.79%

ENSC -1.23%

ENTA 0.77%

ENTO -11.11%

ENTX -4.35%

ENVB -5.90%

EPIX -2.66%

EPRX 2.38%

EPZM 0.00%

EQ -2.21%

EQRX -2.09%

EQRXW 0.00%

ERAS 3.39%

ERNA 4.14%

ERYP 1.30%

ESLA 4.76%

ESLAW 0.00%

ETNB -3.12%

ETON 3.34%

ETTX 0.00%

EVAX 0.70%

EVGN -0.91%

EVLO 39 899.32%

EWTX 7.61%

EXAI 0.98%

EXEL -0.98%

EYEG -0.51%

EYEN 14.27%

EYPT -4.48%

FATE -0.61%

FBIO -1.17%

FBIOP 0.70%

FBLG -19.84%

FBRX 1.68%

FDMT 1.67%

FENC 2.62%

FGEN -13.69%

FHTX 1.57%

FIXX 0.77%

FMTX 0.00%

FNCH -10.95%

FOLD -1.21%

FREQ 4.76%

FRLN 0.15%

FRTX -4.21%

FSTX 0.00%

FTRE 2.23%

FULC 1.77%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.98%

GANX -12.50%

GBIO -8.87%

GBT 0.01%

GDTC -0.99%

GERN 2.36%

GHRS 0.77%

GLMD -1.01%

GLPG 0.93%

GLSI -2.84%

GLTO -1.73%

GLUE 5.35%

GLYC 5.15%

GMAB -1.11%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 10.80%

GNLX -5.64%

GNPX 2.39%

GNTA -0.87%

GOSS 5.18%

GOVX 2.98%

GOVXW -10.37%

GPCR 1.86%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -6.13%

GRTX -8.63%

GTHX 8.33%

GUTS 4.45%

GXGXW 41.67%

GYRE 0.92%

HALO -0.65%

HARP 0.09%

HCWB 0.46%

HEPA -0.93%

HGEN -84.62%

HILS 5.66%

HLVX -0.28%

HOOK 6.17%

HOTH -1.12%

HOWL -3.69%

HRMY 0.83%

HRTX -0.86%

HSTO 0.00%

HUMA 11.88%

HUMAW 22.30%

IBRX -0.79%

ICCC -8.04%

ICPT 0.21%

ICU 23.06%

ICUCW 13.26%

ICVX -0.91%

IDRA -23.04%

IDYA 2.31%

IFRX -1.72%

IGMS -1.16%

IKNA 0.00%

IKT -5.34%

IMAB -2.99%

IMCR 7.49%

IMGN 0.02%

IMGO 0.00%

IMMP 0.00%

IMMX 7.07%

IMNM 0.83%

IMNN 8.62%

IMPL -27.27%

IMRA 15.96%

IMRN -9.26%

IMRX -8.59%

IMTX 3.27%

IMTXW 27.41%

IMUX 0.90%

IMV 0.00%

IMVT 4.20%

INAB -3.95%

INBX -3.03%

INCY 0.41%

INDP 4.25%

INFI -52.38%

INKT -3.51%

INM -5.24%

INMB -4.54%

INO 6.56%

INSM -0.99%

INTS 0.41%

INVA 0.61%

INZY -1.12%

IOBT -4.27%

IONS -1.15%

IOVA 0.50%

IPA -3.71%

IPHA 7.22%

IPSC -5.49%

IRON 3.11%

ISEE 0.38%

ITOS 1.15%

ITRM -5.60%

IVA -1.19%

IVVD 9.09%

JAGX -2.79%

JANX -0.41%

JAZZ -0.24%

JNCE 0.00%

JSPR 1.94%

JSPRW 5.15%

JUNS 0.00%

JUNSW 0.00%

KA 4.20%

KALV 0.93%

KDNY 0.22%

KMPH -0.34%

KNSA -3.59%

KNTE -0.38%

KOD 0.85%

KPRX 3.57%

KPTI -6.01%

KRBP -1.83%

KRON -9.68%

KROS -4.22%

KRRO -0.06%

KRTX 0.03%

KRYS -0.75%

KTRA 10.14%

KTTA 0.38%

KTTAW 1.83%

KURA 2.96%

KYMR 3.69%

KYTX 4.13%

KZIA -4.91%

KZR -2.73%

LABP 0.57%

LBPH 14.39%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.91%

LENZ 2.31%

LEXX -0.72%

LEXXW 23.90%

LGND 0.70%

LGNDV 0.00%

LGVN -2.48%

LIAN -8.28%

LIFE 2.70%

LIPO -3.41%

LIXT -0.38%

LIXTW -3.71%

LJPC -0.32%

LMNL 0.12%

LOGC -3.15%

LPCN -6.31%

LPTX -4.59%

LQDA 0.33%

LRMR 13.66%

LSTA 2.31%

LTRN -3.21%

LUMO -2.46%

LVTX 3.89%

LXEO -2.68%

LXRX -0.30%

LYEL 8.97%

LYRA 7.30%

MACK 0.10%

MBIO 2.41%

MBRX -1.15%

MCRB -0.25%

MDGL -0.30%

MDNA -13.16%

MDWD -0.84%

MDXG -3.32%

MEIP -2.06%

MESO -0.44%

MGNX 1.18%

MGTA -7.74%

MGTX -2.61%

MGX 8.33%

MIRM -0.09%

MIRO 0.59%

MIST 0.75%

MITO 0.00%

MLEC -0.88%

MLECW -31.50%

MLND -5.36%

MLTX -4.94%

MLYS 4.02%

MNKD -2.49%

MNMD -1.94%

MNOV 0.00%

MNPR -0.88%

MOLN 2.80%

MOR -0.22%

MORF -4.46%

MREO 0.83%

MRKR -0.74%

MRNA -2.36%

MRNS 9.40%

MRSN -1.99%

MRTX -0.17%

MRUS -7.98%

MRVI -3.07%

MTCR -1.29%

MTEM 2.61%

MTP -18.50%

MURA -0.96%

MYMD 0.00%

NAMS 7.13%

NAMSW -4.76%

NAUT -2.99%

NBRV 0.71%

NBSE -1.56%

NBTX 7.00%

NCNA 7.36%

NERV -0.86%

NEXI -6.90%

NGM -1.28%

NGNE 11.62%

NKGN 0.00%

NKGNW -12.00%

NKTR -1.61%

NKTX -1.02%

NLSP -9.50%

NLSPW 26.58%

NMRA 1.12%

NMTR -42.97%

NOVN -24.84%

NRBO -6.20%

NRIX 0.19%

NRSN -3.57%

NRSNW -2.91%

NRXP 5.74%

NRXPW 41.43%

NRXS 1.44%

NTBL -6.12%

NTEC -12.45%

NTHI 0.00%

NTLA 0.40%

NTRBW 74.65%

NUVL -0.46%

NVAX 0.55%

NVCT -2.37%

NVIV -34.28%

NXTC -5.66%

NYMX -0.05%

OABI -0.27%

OABIW -9.28%

OBIO -12.64%

OBSV 0.00%

OCEA -3.28%

OCGN 4.84%

OCS -0.50%

OCUL -2.63%

OCUP 3.92%

ODT -4.27%

OKYO 1.64%

OLMA 2.96%

OMER -2.71%

OMGA 8.70%

ONCO -6.10%

ONCR -3.08%

ONCS 31.87%

ONCT -7.70%

ONCY 0.53%

ONTX -0.47%

ONVO -0.34%

OPNT 0.00%

OPT -0.99%

ORGS 8.13%

ORIC 8.06%

ORMP -0.39%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.41%

OVID 12.09%

OYST 0.00%

PALI -5.29%

PASG 11.43%

PBLA -10.00%

PBM 6.33%

PBYI 0.61%

PCSA -7.11%

PCVX 1.89%

PDSB 3.41%

PEPG 12.22%

PGEN -1.90%

PHAR -4.62%

PHAS 0.00%

PHAT 4.95%

PHIO -3.88%

PHIOW 36.47%

PHVS -0.59%

PHXM -5.20%

PIRS -1.82%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 1.02%

PLUR -0.43%

PMN 6.67%

PMVP -2.47%

PNT 0.16%

PPBT -13.47%

PRAX -0.41%

PRDS 0.93%

PRLD -1.05%

PROG -3.47%

PROK 1.63%

PRQR -0.60%

PRTA -0.78%

PRTC 3.68%

PRTG -7.63%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 2.04%

PSTX 3.08%

PTCT 1.93%

PTE -0.82%

PTGX 1.59%

PTIXW -48.41%

PULM 1.55%

PXMD -1.27%

PYPD -0.24%

PYXS -3.32%

QLGN -3.77%

QNCX -3.33%

QNRX 1.75%

QSI -11.01%

QSIAW 4.08%

QTTB 5.74%

QURE -0.78%

RAIN -1.63%

RANI 0.53%

RAPT -5.57%

RARE 0.05%

RCKT -4.04%

REGN 0.57%

RENB -10.86%

REPL 4.00%

RETA 0.02%

REUN -0.89%

REVB -1.58%

REVBU 3.46%

REVBW 0.00%

RGLS 6.44%

RGNX -5.38%

RIGL 2.31%

RLAY -1.84%

RLMD 2.33%

RLYB 1.49%

RNA 1.05%

RNAC -10.14%

RNAZ -4.54%

RNXT 1.77%

ROIV 2.46%

ROIVW 4.56%

RPHM 2.65%

RPRX -0.68%

RPTX 0.91%

RUBY 2.70%

RVLP -32.05%

RVMD 0.00%

RVMDW -1.40%

RVNC 0.00%

RVPH -7.03%

RVPHW 4.88%

RXDX 0.09%

RXRX -0.53%

RYTM 3.92%

RYZB 0.02%

RZLT 0.23%

SABS -1.94%

SABSW 54.57%

SAGE 1.57%

SANA 0.18%

SAVA -1.70%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 3.16%

SCPH -0.69%

SCPS 0.00%

SEEL 3.69%

SEER 0.60%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -7.90%

SGMT -7.60%

SGTX -2.56%

SIOX 22.63%

SLDB 10.58%

SLGL -4.21%

SLN -1.37%

SLNO 3.65%

SLRX -7.92%

SLS -0.84%

SMMT 4.36%

SNDX 4.87%

SNGX -4.26%

SNPX 1.97%

SONN -0.80%

SPPI -0.49%

SPRB 2.55%

SPRC -5.98%

SPRO -1.54%

SRNE -20.00%

SRPT -0.79%

SRRA 0.00%

SRRK -2.40%

SRZN -2.28%

STAB 0.00%

STOK 2.66%

STRO 4.10%

STSA 0.00%

STTK 3.37%

SURF -0.93%

SVRA 15.14%

SWTX 2.28%

SYBX -0.67%

SYRS -4.46%

TALS -0.73%

TARA 0.48%

TARS 3.90%

TBPH 0.47%

TCBP 1.76%

TCDA 0.00%

TCON -30.63%

TCRR 0.00%

TCRT -6.87%

TCRX 1.37%

TECH -0.06%

TENX -1.32%

TERN 0.59%

TFFP 7.23%

TGTX 2.02%

THRX 0.12%

TIL 0.10%

TLC 0.00%

TLSA -3.63%

TNGX 4.90%

TNXP 4.96%

TNYA 8.71%

TPST -2.28%

TRDA 0.49%

TRVI -3.02%

TRVN -3.81%

TSHA 0.89%

TSVT 5.19%

TTNP -0.18%

TVTX 0.73%

TYRA 8.07%

UBX -1.48%

UNCY 7.76%

URGN -1.79%

UTHR 0.14%

VACC 11.36%

VALN -3.27%

VAXX 20.24%

VBIV 4.85%

VBLT -8.77%

VCEL -1.85%

VCNX -0.15%

VCYT -1.57%

VERA 0.30%

VERU 4.45%

VERV 2.05%

VIGL 9.25%

VINC -6.26%

VIR 2.25%

VIRI 3.26%

VIRX -6.20%

VKTX 4.36%

VLON -13.04%

VNDA -1.24%

VOR -1.07%

VRCA 9.05%

VRDN 1.54%

VRNA 7.26%

VRPX -1.59%

VRTX 0.54%

VSTM 9.06%

VTGN 2.59%

VTVT -0.42%

VTYX -2.16%

VXRT 3.19%

VYGR -0.63%

VYNE -2.54%

VYNT 7.78%

WINT 0.00%

WVE 4.91%

XBIO -0.48%

XBIT 7.98%

XCUR -3.93%

XENE -3.33%

XERS -3.56%

XFOR 1.62%

XLO -2.49%

XLRN 0.00%

XNCR 0.48%

XOMA 5.11%

XOMAO 0.20%

XOMAP 1.98%

XRTX -1.06%

YMAB -2.07%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -0.23%

ZNTL 2.45%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-07	Scimeca Dario	Buy	301	Common Stock
2024-06-10	Scimeca Dario	Sell	93	Common Stock
2024-06-07	Scimeca Dario	Sell	301	Restricted Stock Units
2024-06-07	Kelly John Alexander	Buy	454	Common Stock
2024-06-07	Kelly John Alexander	Sell	454	Restricted Stock Units

INSIDER POWER
16.98
Last 100 transactions
Buy: 2 416 792 \| Sell: 1 514 637

Correlation (AI algo v.1.1b): Overvalued: -0.93% $9.89 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.12 (neutral)

Short: -0.55 (weak negative)

Signal:(50.409) Neutral

Precision BioSciences Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Precision BioSciences Inc Correlation - Currency/Commodity

0.65
( moderate )

0.72
( moderate )

0.00
( neutral )

0.78
( moderate )

0.77
( moderate )

0.37
( neutral )

Precision BioSciences Inc Financials

Annual	2023
Revenue:	$48.73M
Gross Profit:	$40.47M (83.06 %)
EPS:	$-18.16

FY	2023
Revenue:	$48.73M
Gross Profit:	$40.47M (83.06 %)
EPS:	$-18.16

FY	2022
Revenue:	$25.10M
Gross Profit:	$16.09M (64.12 %)
EPS:	$-41.95

FY	2021
Revenue:	$115.53M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.520

Financial Reports:

No articles found.

Precision BioSciences Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Precision BioSciences Inc

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma. The company has development and commercial license agreement with Les Laboratoires Servier to develop allogeneic chimeric antigen receptor T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; and iECURE, Inc. to develop ARCUS-based gene editing therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.